34,430 Shares in M.D.C. Holdings, Inc. (NYSE:MDC) Acquired by New England Research & Management Inc.

New England Research & Management Inc. purchased a new stake in M.D.C. Holdings, Inc. (NYSE:MDC) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 34,430 shares of the construction company’s stock, valued at approximately $1,098,000. New England Research & Management Inc. owned 0.06% of M.D.C. at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Amalgamated Bank acquired a new stake in M.D.C. during the second quarter worth approximately $202,000. Capital Fund Management S.A. bought a new position in M.D.C. in the second quarter worth approximately $223,000. Sawgrass Asset Management LLC bought a new position in M.D.C. in the third quarter worth approximately $262,000. Parametrica Management Ltd bought a new position in M.D.C. in the third quarter worth approximately $285,000. Finally, Campbell & CO Investment Adviser LLC bought a new position in M.D.C. in the third quarter worth approximately $306,000. 74.15% of the stock is owned by institutional investors.

MDC has been the topic of several recent research reports. ValuEngine lowered M.D.C. from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 2nd. Citigroup dropped their target price on M.D.C. from $37.00 to $34.00 and set a “neutral” rating on the stock in a report on Friday, November 3rd. KeyCorp restated a “hold” rating on shares of M.D.C. in a report on Tuesday, September 26th. Zacks Investment Research upgraded M.D.C. from a “sell” rating to a “hold” rating in a report on Wednesday, October 4th. Finally, UBS Group started coverage on M.D.C. in a report on Wednesday, October 25th. They issued a “sell” rating and a $34.00 target price on the stock. Four investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $30.33.

In other news, Director David Siegel sold 2,500 shares of M.D.C. stock in a transaction on Friday, December 8th. The stock was sold at an average price of $31.83, for a total value of $79,575.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Herbert T. Buchwald sold 28,350 shares of M.D.C. stock in a transaction on Friday, December 15th. The shares were sold at an average price of $31.52, for a total value of $893,592.00. The disclosure for this sale can be found here. Company insiders own 25.30% of the company’s stock.

Shares of M.D.C. Holdings, Inc. (NYSE MDC) traded down $0.22 on Tuesday, hitting $34.12. The company had a trading volume of 365,400 shares, compared to its average volume of 546,700. The company has a quick ratio of 2.60, a current ratio of 9.45 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $1,914.08, a P/E ratio of 12.24, a price-to-earnings-growth ratio of 0.88 and a beta of 1.36. M.D.C. Holdings, Inc. has a one year low of $25.87 and a one year high of $37.45.

M.D.C. (NYSE:MDC) last issued its quarterly earnings results on Thursday, November 2nd. The construction company reported $1.16 EPS for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.55. M.D.C. had a return on equity of 11.66% and a net margin of 6.09%. The company had revenue of $586.30 million during the quarter, compared to the consensus estimate of $595.05 million. During the same period last year, the business posted $0.54 earnings per share. M.D.C.’s revenue was up 1.4% on a year-over-year basis. sell-side analysts anticipate that M.D.C. Holdings, Inc. will post 2.69 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This story was originally published by BBNS and is the sole property of of BBNS. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://baseballnewssource.com/markets/new-england-research-management-inc-purchases-shares-of-34430-m-d-c-holdings-inc-mdc/1820842.html.

About M.D.C.

M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.

Institutional Ownership by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets


Leave a Reply

 
© 2006-2018 BBNS.